<DOC>
	<DOCNO>NCT01316393</DOCNO>
	<brief_summary>In present study randomize , cross-over , blind , placebo control design , effect salivary substitute product new mucoprotective product similar mechanisms action different composition characteristic evaluate cancer patient suffer xerostomia .</brief_summary>
	<brief_title>Effects Mucoprotective Product Xerostomia</brief_title>
	<detailed_description />
	<mesh_term>Xerostomia</mesh_term>
	<criteria>1 . The patient must least 18 year age . 2 . The patient must clinical symptom xerostomia ( dry mouth ) due treatment head neck cancer 3 . The patient must understand consent write procedure . 1 . Do meet criterion `` dry mouth '' regard saliva secretion threshold value . 2 . Known allergy ingredient product use trial and/or allergy soy , peanut , citrus fruit , Yerba Santa methyl parabene 3 . Patients unable unwilling cooperate study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>xerostomia , saliva , mucoprotection , oral health</keyword>
</DOC>